SCHEMBL6986532

SCHEMBL6986532

NC(=O)C(F)(F)c1ccccc1.NCC(F)(F)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44
KCNN4 O15554 8/20 0.43
HTT P42858 1/20 0.41
TAAR1 Q96RJ0 1/20 0.38
KCNE1 P15382 1/20 0.37
KCNQ1 P51787 1/20 0.37
PTPN1 P18031 1/20 0.37
CNR1 P21554 1/20 0.37
EPHX1 P07099 1/20 0.37
KIF11 P52732 1/20 0.36
KDM4E B2RXH2 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA5A P35218 1/20 0.36
CA9 Q16790 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2465581 0.87 MAPT (0.56) MAPTKMT2AKCNN4HTTKCNE1
SCHEMBL506977 0.82 TAAR1 (0.52) KCNN4TAAR1PTPN1KIF11CA1
Hydrochloric Acid SCHEMBL9280100 0.80 TAAR1 (0.50) KCNN4TAAR1PTPN1KIF11CA1
SCHEMBL28733068 0.74 MAPT (0.47) MAPTKMT2AKCNN4HTTKCNE1
SCHEMBL16212235 0.73 PTPN1 (0.47) MAPTKMT2AKCNN4HTTPTPN1
Choline SCHEMBL15993997 0.72 LMNA (0.43) MAPTKMT2AKCNN4HTTKDM4E
SCHEMBL28140828 0.71 MAPT (0.52) MAPTKMT2AKCNN4HTTTAAR1
SCHEMBL19566546 0.71 KIF11 (0.58) TAAR1PTPN1KIF11
SCHEMBL23588020 0.70 KIF11 (0.55) KMT2AKCNN4PTPN1KIF11KDM4E
SCHEMBL17968493 0.70 MAPT (0.56) MAPTKMT2AKCNN4HTTKCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1303510-A2 CYCLIC OXYGUANIDINE PYRAZINONES AS PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2003-04-23 EP disclosed
WO-2002006248-A2 CYCLIC OXYGUANIDINE PYRAZINONES AS PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-01-24 WO disclosed